3Lu Shen-jing,Nicholas Doy,Lanrent Degosl,et al. Linkage of a nasopharyngeal carcinoma susceptibilty locus the HLAregion. Nature 1990;346:245
4Fahraeus R, Ryno L, Rhim JS, et al. Morphological transformation of human Keratinocytes expression the LMP gene of Epstein-Barr virus. Nature 1990 ;345: 447
5Hu LF, Chen F, Zheng X, et al. Clonability and tumorigenicity of human epithelial cell expression the EBV encoded membrane protein LMP1. Oncogene1993;8(6):1575
6Hennessy, Fennewld S, Hummel M, et al. A membrane protein encoded by Epstein-Barr virus in latent growthtransforming infection. Proc Natl Acad Sci USA 1984:81: 7207
7Moas D. Cytotoxin T-cell recognition of Epstein-Barr virus infection B-cell I specificity and HLA restriction of effector cell reactivated in vitro. Eur J Immunol 1981; 11:686
8Rajiv,Khanna,Busson,et al. Molecular characterization of antigen-procession function in nasopharygeal carcinoma (NPC): Evidence for efficient presentation of Epstein-Barr virus cytotoxic-cell. epitopes by NPC cell. Cancer Res 1998,58(2):310
9Blahe H,Les S,Redchenko I,et al. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing, Immunity 1997;7(6):791
10Khanna K,Burrows SR,Steigerwald-Mullen PM,et al. Targeting Epstein-Barr virus antigen 1 (EBNA1)through the class Ⅱ pathway restores immune recognition by EBNA 1-specific cytotoxic T lymphocytyes: evidence for HLA-DM-independent processing. Int Immunol 1997;9(10):1537
